BerGenBio ASA reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was NOK 72 million compared to NOK 81.07 million a year ago. Basic loss per share from continuing operations was NOK 0.81 compared to NOK 0.92 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.137 NOK | 0.00% | -5.52% | -50.72% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.72% | 49.12M | |
+3.28% | 108B | |
+10.28% | 105B | |
+1.57% | 23.46B | |
-12.90% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-7.18% | 17.19B | |
+5.79% | 13.99B | |
+36.63% | 12.53B |
- Stock Market
- Equities
- BGBIO Stock
- News BerGenBio ASA
- BerGenBio ASA Reports Earnings Results for the First Quarter Ended March 31, 2023